Literature DB >> 15388643

Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase.

Gary L Baumbach1, Curt D Sigmund, Frank M Faraci.   

Abstract

We examined effects of pharmacological inhibition of nitric oxide synthase (NOS) and genetic deficiency of the endothelial isoform of NOS (eNOS) on structure and mechanics of cerebral arterioles. We measured pressure, diameter, and cross-sectional area (CSA) of the vessel wall (histologically) in maximally dilated cerebral arterioles in mice that were untreated or treated for 3 months with the NOS inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME; 10 mg/kg per day in drinking water). Treatment with L-NAME increased systemic arterial mean pressure (SAP; 143+/-4 versus 121+/-4 mm Hg, P<0.05) and CSA (437+/-27 versus 310+/-34 microm2, P<0.05). These findings suggest that hypertension induced in mice by NOS inhibition is accompanied by hypertrophy of cerebral arterioles. To determine the role of the eNOS isoform in regulation of cerebral vascular growth, we examined mice with targeted disruption of one (heterozygous) or both (homozygous) genes encoding eNOS. Wild-type littermates served as controls. SAP and CSA were significantly increased in homozygous (SAP, 141+/-5 versus 122+/-3 mm Hg in wild-type mice, P<0.05; CSA, 410+/-18 versus 306+/-15 microm2 in wild-type mice, P<0.05), but not in heterozygous (SAP, 135+/-4 mm Hg; CSA, 316+/-32 microm2) eNOS-deficient mice. Carotid ligation normalized cerebral arteriolar pulse pressure did not prevent increases in CSA in homozygous eNOS-deficient mice. Thus, cerebral arterioles undergo hypertrophy in homozygous eNOS-deficient mice, even in the absence of increases in arteriolar pulse pressure. These findings suggest that eNOS plays a major role in regulation of cerebral vascular growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388643     DOI: 10.1161/01.RES.0000146279.11923.14

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  25 in total

1.  Enhanced brain release of erythropoietin, cytokines and NO during carotid clamping.

Authors:  Stephana Carelli; Giorgio Ghilardi; Paola Bianciardi; Elisa Latorre; Federico Rubino; Marina Bissi; Anna Maria Di Giulio; Michele Samaja; Alfredo Gorio
Journal:  Neurol Sci       Date:  2015-10-22       Impact factor: 3.307

Review 2.  Hypertension and cerebrovascular dysfunction.

Authors:  Costantino Iadecola; Robin L Davisson
Journal:  Cell Metab       Date:  2008-06       Impact factor: 27.287

Review 3.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 4.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

5.  Vascular Arginase Is a Relevant Target to Improve Cerebrovascular Endothelial Dysfunction in Rheumatoid Arthritis: Evidence from the Model of Adjuvant-Induced Arthritis.

Authors:  Romain Bordy; Aurore Quirié; Christine Marie; Daniel Wendling; Perle Totoson; Céline Demougeot
Journal:  Transl Stroke Res       Date:  2019-03-18       Impact factor: 6.829

6.  Catechin prevents severe dyslipidemia-associated changes in wall biomechanics of cerebral arteries in LDLr-/-:hApoB+/+ mice and improves cerebral blood flow.

Authors:  Virginie Bolduc; Edward Baraghis; Natacha Duquette; Nathalie Thorin-Trescases; Jean Lambert; Frédéric Lesage; Eric Thorin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-20       Impact factor: 4.733

Review 7.  Microvascular Dysfunction and Cognitive Impairment.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

8.  Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice.

Authors:  Virginie Bolduc; Annick Drouin; Marc-Antoine Gillis; Natacha Duquette; Nathalie Thorin-Trescases; Isabelle Frayne-Robillard; Christine Des Rosiers; Jean-Claude Tardif; Eric Thorin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-16       Impact factor: 4.733

9.  The mitochondrial thioredoxin reductase system (TrxR2) in vascular endothelium controls peroxynitrite levels and tissue integrity.

Authors:  Petra Kameritsch; Miriam Singer; Christoph Nuernbergk; Natalia Rios; Aníbal M Reyes; Kjestine Schmidt; Julian Kirsch; Holger Schneider; Susanna Müller; Kristin Pogoda; Ruicen Cui; Thomas Kirchner; Cor de Wit; Bärbel Lange-Sperandio; Ulrich Pohl; Marcus Conrad; Rafael Radi; Heike Beck
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

10.  Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling.

Authors:  Andreas M Beyer; Gary L Baumbach; Carmen M Halabi; Mary L Modrick; Cynthia M Lynch; Thomas D Gerhold; Shams M Ghoneim; Willem J de Lange; Henry L Keen; Yau-Sheng Tsai; Nobuyo Maeda; Curt D Sigmund; Frank M Faraci
Journal:  Hypertension       Date:  2008-02-19       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.